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Abstract
Cocaine promotes addictive behavior primarily by blocking the dopamine transporter, thus 
increasing dopamine transmission in the nucleus accumbens (nAcc); however, additional 
mechanisms are continually emerging. Sigma-1 receptors (σ1Rs) are known targets for cocaine, 
yet the mechanisms underlying σ1R-mediated effects of cocaine are incompletely understood. The 
present study examined direct effects of cocaine on dissociated nAcc neurons expressing 
phosphatidylinositol-linked D1 receptors. Endoplasmic reticulum-located σ1Rs and inositol 1,4,5-
trisphosphate (IP3) receptors (IP3Rs) were targeted using intracellular microinjection. IP3 
microinjection robustly elevated intracellular Ca2+ concentration, [Ca2+]i. While cocaine alone 
was devoid of an effect, the IP3-induced response was σ1R-dependently enhanced by cocaine co-
injection. Likewise, cocaine augmented the [Ca2+]i increase elicited by extracellularly applying an 
IP3-generating molecule (ATP), via σ1Rs. The cocaine-induced enhancement of the P3/ATP-
mediated Ca2+ elevation occurred at pharmacologically relevant concentrations and was mediated 
by transient receptor potential canonical channels (TRPC). IP3 microinjection elicited a slight, 
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transient depolarization, further converted to a greatly enhanced, prolonged response, by cocaine 
co-injection. The cocaine-triggered augmentation was σ1R-dependent, TRPC-mediated and 
contingent on [Ca2+]i elevation. ATP-induced depolarization was similarly enhanced by cocaine. 
Thus, we identify a novel mechanism by which cocaine promotes activation of D1-expressing 
nAcc neurons: enhancement of IP3R-mediated responses via σ1R activation at the endoplasmic 
reticulum, resulting in augmented Ca2+ release and amplified depolarization due to subsequent 
stimulation of TRPC. In vivo, intra-accumbal blockade of σ1R or TRPC significantly diminished 
cocaine-induced hyperlocomotion and locomotor sensitization, endorsing a physio-pathological 
significance of the pathway identified in vitro.
Graphical Abstract
Keywords
sigma receptors; transient receptor potential channels; calcium; endoplasmic reticulum; imaging; 
nucleus accumbens
1. Introduction
Pharmacotherapy of cocaine addiction is particularly ineffective in that addicts invariably 
relapse to drug use [1–3]. The study of cocaine action in the brain has unraveled newer 
mechanisms, of continually emerging complexity. The initial rewarding effects of cocaine 
are attributed to increased dopamine levels in the nucleus accumbens (nAcc)¶ achieved by 
inhibition of the dopamine transporter [4, 5], however, the transition to cocaine dependence 
likely involves other cellular processes. Further, a multitude of cocaine-induced responses 
are strictly contingent on D1 dopamine-receptor activation [6–8], occurring only in D1-
expressing neurons [7], supporting the existence of additional mechanisms.
Cocaine is a known ligand of sigma-1 receptors (σ1Rs) [9], which are chaperone proteins 
residing at the endoplasmic reticulum in a dormant state, but able to relocate to other areas 
of the cell in response to agonist stimulation, and change their degree of interaction with 
several other chaperone proteins, favoring activation of various types of receptors and ion 
channels [10, 11]. Involvement of σ1Rs in modulation of dopaminergic transmission and 
addictive processes has long been recognized [12, 13]. σ1Rs are expressed in the nAcc, a key 
node in the circuit that controls reward-directed behavior [14, 15], and have been proposed 
as a pharmacologic target in the treatment of cocaine abuse [16, 17].
Data from in vivo animal studies point to involvement of σ1Rs in cocaine-induced responses. 
Cocaine self-administration triggers σ1Rs-mediated reinforcing effects that are absent in 
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subjects without that particular experience with cocaine, and are dopamine-independent [18, 
19]. Administration of σ1Rs agonists potentiates the reinforcing effects of cocaine [19]. 
Conversely,σ1R antagonists attenuate psychomotor and rewarding effects of cocaine [12, 
13]. σ1R-blockade inhibits cocaine-induced place conditioning in mice [20, 21].
At the cellular level, cocaine induces an association of σ1Rs and D1 dopamine receptors, 
which results in cAMP accumulation and ERK1/2 activation in transfected cells and mouse 
striatal slices [22]. Conversely, cocaine promotes formation of σ1R-D2 dopamine receptor 
heterooligomers, inhibiting D2-mediated signaling [23]. Thus cocaine putatively destabilizes 
the balance of D1 and D2 receptor inputs, via σ1Rs, towards the D1 containing, pro-reward 
and motivating pathway [23]. However, a clear mechanism of cocaine-mediated 
enhancement of D1-pathway via σ1Rs remains elusive.
Activation of σ1Rs is associated with prolonged Ca2+ efflux from the endoplasmic reticulum 
(ER) through inositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs) [10, 24]. The present study 
uses calcium imaging and intracellular microinjection to explore the mechanisms of cocaine-
triggered activation of D1-expressing neurons, focusing on intracellularly-located σ1Rs.
2. Materials and methods
2.1. Ethical approval
Animal protocols were approved by the Institutional Animal Care and Use Committees from 
Temple University and Thomas Jefferson University.
2.2. Chemicals
All chemicals were from Sigma Aldrich (St. Louis, MO), unless otherwise mentioned. 
Cocaine hydrochloride was generously supplied by NIDA; NE-100 hydrochloride was from 
Santa Cruz Biotechnology (Dallas, TX). In experiments using intracellular microinjection, 
the reported concentration of chemicals is the calculated final concentration inside the cell. 
In experiments using ATP and extracellular administration of cocaine, the cells were 
pretreated with cocaine for 10 minutes, a time sufficient to allow intracellular uptake of 
cocaine. In experiments using IP3 and cocaine, there was no pretreatment phase.
2.3. Western blotting
Whole-cell lysates obtained from rat nucleus accumbens and NG108-15 cells (mouse 
neuroblastoma x rat glioma) were separated on Mini-PROTEAN TGX 4–20% gels (Bio-
Rad, Hercules, CA) by SDS-PAGE followed by immunoblotting. Proteins were transferred 
to an Odyssey nitrocellulose membrane (Li-Cor Biosciences; Lincoln, NE). After blocking 
with Odyssey blocking buffer, the membranes were incubated overnight with primary 
antibody against σ1R (rabbit polyclonal, 1:100, OriGene Technologies, Rockville, MD), or 
IP3R3 (mouse monoclonal, 1:1,000, BD Biosciences, San Jose, CA). An antibody against β-
actin (mouse monoclonal, 1:10,000; Sigma Aldrich) was used to confirm equal protein 
loading. Membranes were washed with Tris-buffered saline-Tween 20 (TBST) and 
incubated with the secondary antibodies: IRDye 800CW conjugated goat anti-rabbit IgG, 
and IRDye 680 conjugated goat anti-mouse IgG (1:10,000, 1 h at room temperature). 
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Membranes were then washed in TBST and scanned using Li-Cor Odyssey Infrared and 
Odyssey V.3 software.
2.4. Neuronal cell culture
Nucleus accumbens neurons were dissociated from neonatal (1–2 day old) Sprague Dawley 
rats (Ace Animal Inc., Boyertown, PA) of both sexes as previously described [25]. Newborn 
rats were decapitated and the brains quickly removed surgically and immersed in ice-cold 
Hanks balanced salt solution (HBSS) (Mediatech, Herndon, VA). The nucleus accumbens 
was identified, removed, minced and subjected to enzymatic digestion (papain, 37°C), 
followed by mechanical trituration in presence of total medium – Neurobasal A (Invitrogen, 
Carlsbad, CA) containing 1% GlutaMax (Invitrogen), 2% penicillin-streptomycin-
amphotericin B solution (Mediatech) and 10% fetal bovine serum. Cells were cultured on 
round 25 mm glass coverslips coated with poly-L-lysine (Sigma-Aldrich) in six-well plates. 
Cultures were maintained at 37°C in a humidified atmosphere with 5% CO2. The mitotic 
inhibitor cytosine β-arabinofuranoside (1μM) (Sigma-Aldrich) was added to the culture the 
third day to inhibit glial cell proliferation. Cells were used after 5 days in culture.
2.5. Calcium imaging
[Ca2+]i was measured as previously described [25]. Cells were incubated with 5 μM fura-2 
AM (Invitrogen, Carlsbad, CA) in HBSS at room temperature for 45 min, in the dark, 
washed three times with dye-free HBSS, and then incubated for another 45 min to allow for 
complete de-esterification of the dye. Coverslips (25 mm diameter) were subsequently 
mounted in an open bath chamber (RP-40LP, Warner Instruments, Hamden, CT) on the 
stage of an inverted microscope Nikon Eclipse TiE (Nikon Inc., Melville, NY). The 
microscope is equipped with a Perfect Focus System and a Photometrics CoolSnap HQ2 
CCD camera (Photometrics, Tucson, AZ). During the experiments, the Perfect Focus 
System was activated. Fura-2 AM fluorescence (emission = 510 nm), following alternate 
excitation at 340 and 380 nm, was acquired at a frequency of 0.25 Hz. Images were acquired 
and analyzed using NIS-Elements AR 3.1 software (Nikon Inc.). After appropriate 
calibration with ionomycin and CaCl2, and Ca2+ free and EGTA, respectively, the ratio of 
the fluorescence signals (340/380 nm) was converted to Ca2+ concentrations. In Ca2+-free 
experiments, CaCl2 was omitted.
2.6. Intracellular microinjection
Intracellular microinjections were performed using FemtotipsII, InjectManNI2 and FemtoJet 
systems (Eppendorf) as reported [25]. Pipettes were back-filled with an intracellular solution 
containing, in mM: 110 KCl, 10 NaCl and 20 HEPES (pH 7.2) or the compounds to be 
tested. The injection time was 0.4 s at 60 hPa with a compensation pressure of 20 hPa in 
order to maintain the microinjected volume to less than 1% of cell volume, as measured by 
microinjection of a fluorescent compound (Fura-2 free acid). The intracellular concentration 
of chemicals was determined based on the concentration in the pipette and the volume of 
injection. The cells to be injected were Z-scanned before injection and the cellular volume 
automatically calculated by the NIS-Elements AR 3.1 software (Nikon, Inc.).
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2.7. Measurement of membrane potential
The relative changes in membrane potential of single neurons were evaluated using bis-(1,3-
dibutylbarbituric acid) trimethine oxonol, DiBAC4(3), a slow response voltage-sensitive 
dye, as previously described [25]. Upon membrane hyperpolarization, the dye concentrates 
in the cell membrane, leading to a decrease in fluorescence intensity, while depolarization 
induces the sequestration of the dye into the cytosol, resulting in an increase of the 
fluorescence intensity. Cultured accumbens neurons were incubated for 30 min in HBSS 
containing 0.5 μM DiBAC4(3) and the fluorescence monitored at 0.17 Hz, excitation/
emission: 480 nm/540 nm. Calibration of DiBAC4(3) fluorescence following background 
subtraction was performed using the Na+-K+ ionophore gramicidin in Na+-free 
physiological solution and various concentrations of K+ (to alter membrane potential) and 
N-methylglucamine (to maintain osmolarity). Under these conditions, the membrane 
potential was approximately equal to the K+ equilibrium potential determined by the Nernst 
equation. The intracellular K+ and Na+ concentration were assumed to be 130 mM and 10 
mM, respectively.
2.8. Data analysis
Data obtained after in vitro experiments are expressed as mean and standard error of mean. 
One way ANOVA, followed by post-hoc Bonferroni and Tukey tests (Origin 7, OriginLab 
Corporation, Northampton, MA), were used to assess significant differences between 
groups; P < 0.05 was considered statistically significant.
2.9. In vivo experiments
Male Sprague–Dawley rats, weighing 250–280 g at the time of surgery, were individually 
housed under standard conditions. Two 26 gauge stainless steel guide cannulas directed 
bilaterally at the nucleus accumbens (nAcc) (± 0.9 mm lateral, 1.6 mm anterior, and 5.8 mm 
ventral to bregma) were stereotaxically implanted under isofluorane anesthesia. Dummy 
cannulae that extended 1 mm beyond the tip of the guide cannula were inserted immediately 
after surgery. Rats were handled and habituated to infusion procedures for 2–3 days before 
testing began. On test Days 1–5, rats were placed in individual automated activity monitors 
containing 16 infrared light emitters and sensors mounted on a frame within which a 
standard plastic animal cage was positioned (45 × 20 × 20 cm; AccuScan Instruments, Inc., 
Columbus, OH, USA). The number of photocell beam breaks was recorded by a computer 
equipped with Digiscan DMicro software (AccuScan Instruments). Following a 60 min 
habituation period, bilateral infusions of vehicle (0.5 μl, artificial cerebrospinal fluid 
(aCSF)) or BD-1063 (80 μg/0.5 μl, ab141323, Abcam, Cambridge, MA) or SKF-96365 (20 
μg/0.5 μl, S7809, Sigma-Aldrich, St Louis, MO) were made into the nAcc, at a rate of 0.5 
μl/min using a microinfusion pump. The injections cannulae remained in situ for one minute 
after the infusion. Twenty minutes following infusions, rats were injected with saline (1 
ml/kg, intraperitoneal (ip)) or cocaine (15 mg/kg, ip) and behavioral activity monitored for 
another 60 min. This was repeated once daily for 5 days. Following a 7-day withdrawal 
period, all rats were then challenged with cocaine (Day 12, 15 mg/kg, ip) in the absence of 
further intracranial infusions. After testing, brains were removed and fixed in 4% 
paraformaldehyde for three days. Brains were sliced at 60 μm on a vibratome through the 
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nAcc, and stained with cresyl violet to determine the location of the infusion cannula; 
injection sites are shown in Fig. 9a. Data from rats with both placements within the nAcc 
were included in the analysis. Behavioral data were analyzed with two-way repeated 
measures ANOVA. Significant main effects of treatment, day or interactions between 
treatment and day were further assessed with a Student-Newman-Keuls (SNK) post hoc test 
for multiple pair wise comparisons at each time point (Sigmaplot 12.5; Systat Software 
Inc.).
3. Results
3.1. Identification of receptors of interest in cultured nucleus accumbens neurons
We used western blotting to confirm the presence of σ1Rs in cultured nAcc neurons (Fig. 
1a), which is in agreement with previous reports [14, 15]. σ1Rs have been shown to 
associate with type 3 of IP3R (IP3R3) to promote increased Ca2+ efflux from the ER [10, 
24]. We found that both IP3R3 and σ1Rs are expressed in cultured nAcc neurons (Fig. 1a). 
NG108 cells were used as a positive control for IP3R3 and σ1Rs [10].
Since several cocaine-mediated responses are strictly dependent on D1 receptor activation or 
are restricted to D1-expressing neurons [6–8], in the present study we used only neurons 
responding to application of D1 agonist SKF83959 (10 μM) with an increase in [Ca2+]i [26, 
27] (Fig. 1b); accordingly, these neurons were considered D1-positive, signaling via Gq-
coupled pathways [26]. When incubated with Ca2+-free saline, neuronal Ca2+ response to 
application of SKF83959 was reduced from 197 ± 4.6 nM (n = 581 cells in Ca2+-containing 
saline) to 96 ± 3.6 nM (n = 6 cells in Ca2+-free medium) and further, largely abolished by 
presence of IP3R inhibitors xestospongin C (XeC, 10 μM, 15 min) and 2-
aminoethoxydiphenyl borate (2-APB, 100 μM, 15 min) − Δ[Ca2+]i = 7 ± 2.1 nM (n = 6, Fig. 
1b). This indicates that indeed, in the responsive neurons, SKF83959 promotes Ca2+ 
mobilization from intracellular stores via IP3Rs, supporting the activity of a Gq-coupled 
pathway.
s3.2. Cocaine enhances IP3-dependent Ca2+ mobilization via σ1R activation
In D1-expressing neurons incubated with Ca2+-containing saline, microinjection of cocaine 
(100 μM, final concentration inside the cell) did not elicit an increase in [Ca2+]i, the effect 
being similar to that produced by microinjection of control buffer (Fig. 1c); Δ[Ca2+]i was 28 
± 4.7 nM, and the area under curve of the Ca2+ response (A.U.C.) was 33.8 ± 4.4 nM x min 
for cocaine (n = 6 D1-positive nAcc neurons), while for control vehicle the effects measured 
21 ± 4.2 nM and 36.5 ± 3.7 nM x min (n = 6), respectively (Fig. 1c).
In an additional series of experiments, we tested the effect of intracellular administration 
cocaine on IP3-induced Ca2+ response in D1-positive accumbens neurons. To evaluate the 
effect of cocaine co-injection on the Ca2+ mobilization triggered by IP3, additional 
experiments were carried out in Ca2+-free saline, in order to prevent interference with any 
Ca2+ entry mechanism. At 20 nM, IP3 microinjection into D1-positive nAcc neurons 
produced a Ca2+ response of 276 ± 2.8 nM (n = 6 cells), while 10 μM cocaine co-injected 
with 20 nM IP3 triggered a significantly enhanced effect, measuring 364 ± 3.6 nM (n = 6 
cells, Fig. 2a). To establish a concentration-response curve, increasing concentrations of IP3 
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(1–60 nM) were injected either alone or in combination with 10 μM cocaine (n = 5 to 6 cells 
for each concentration tested). The two concentration-response curves are presented in Fig. 
2b; cocaine significantly shifted the IP3 concentration-response curve to the left, diminishing 
the EC50 for IP3 from 22.4 nM (when administered alone) to 17.8 nM (when co-
administered with cocaine).
Blocking σ1Rs with either the selective and prototypical σ1R antagonist BD-1063 [28] (10 
μM, 20 min) or with NE-100 (3 μM, 20 min), another selective σ1R inhibitor [29, 30], was 
sufficient to prevent cocaine-induced augmentation of IP3-mediated Ca2+ mobilization: 
Δ[Ca2+]i were 291 ± 3.3 nM (BD-1063 pretreatment, n = 6 cells) and 285 ± 3.2 nM (NE-100 
pretreatment, n = 6) compared with 364 ± 3.6 nM (10 μM cocaine co-injected with 20 nM 
IP3, no antagonists, n = 6) and 276 ± 2.8 nM (20 nM IP3 alone, n = 6 cells, Fig. 2a, c).
Next, we evaluated the effect of cocaine microinjection on the IP3-induced Ca2+ 
mobilization in Ca2+-containing saline-incubated D1-positive neurons. IP3 (20 nM) 
microinjection alone robustly elevated [Ca2+]i by 332 ± 4.8 nM (A.U.C. of 111 ± 4.4 nM x 
min, n = 6 cells), while in the presence of 10 μM co-injected cocaine, the effect was greatly 
enhanced, measuring 576 ± 5.3 nM in amplitude (A.U.C. of 234 ± 6.1 nM x min, n = 6) 
(Fig. 3a, b). Incubation of neurons with BD-1063 (10 μM, 20 min) reduced the Ca2+ 
response to co-injected cocaine and IP3 to that of IP3 alone (Δ [Ca2+]i was 337 ± 5.8 nM, 
A.U.C. was 104 ± 3.3 nM x min, n = 6, Fig. 3a, b), indicating that the cocaine-triggered 
augmentation was σ1R-mediated. This conclusion is supported by the inability of BD-1063 
to reduce the effect IP3 microinjection alone (Δ [Ca2+]i was 342 ± 5.2 nM, A.U.C. was 114 
± 4.8 nM x min, Fig. 3a, b). To further strengthen our findings, we evaluated whether the 
σ1R antagonist NE-100 would block the cocaine-mediated enhancement of IP3-induced 
Ca2+ response: indeed, similar to the effects seen in presence of extracellular Ca2+, 20 min 
pretreatment of neurons with 3 μM NE-100 resulted in a significant reduction of the Ca2+ 
increase promoted by IP3 and cocaine co-injection, the response measuring 341 ± 5.2 nM in 
amplitude and having an A.U.C. of 108 ± 4.8 nM x min (Fig. 3a, b). Noteworthy, σ1R 
blockade by either BD-1063 or NE-100 had largely identical diminishing effect on the 
response triggered by combined cocaine and IP3 administration, both in the presence and in 
the absence of extracellular Ca2+.
In presence of the fast Ca2+ chelator BAPTA-AM (200 μM, 30 min incubation), combined 
intracellular administration of cocaine and IP3 produced a small and insignificant response, 
measuring 49 ± 4.1 nM in amplitude and with an A.U.C. of 14 ± 3.3 nM x min (n = 6, Fig. 
3a, b). In presence of SKF96365 (2 μM), that blocks receptor- and store-operated Ca2+ entry 
via transient receptor potential canonical (TRPC) channels [31, 32], the cocaine-induced 
potentiation was abolished (Δ[Ca2+]i was 268 ± 6.4 nM, A.U.C. of 76 ± 4.6 nM x min, n = 
6, Fig. 3a, b). Fig. 3c depicts representative examples of changes in 340 nm/380 nm Fura-2 
fluorescence ratio of nAcc neurons in presence of D1 agonist SKF83959, followed (after 
washing of SKF83959) by intracellular microinjection of IP3 alone or IP3 and cocaine, in 
absence and presence of the indicated antagonists.
Next, we tested whether cocaine might amplify Ca2+ responses induced by another 
intracellular Ca2+ release mediator, cyclic ADP ribose (cADPR), which acts on ryanodine 
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receptors [33]. Because cADPR has also been involved in the activation of TRPM2 (also 
known as TRPC7 or LTRPC2) [34, 35], to avoid any TRPC-mediated effect, experiments 
were performed in absence of extracellular Ca2+. In cells incubated with Ca2+-free saline, 
cADPR (20 μM) injection elevated [Ca2+]i by 174 ± 2.8 nM (A.U.C. of 52 ± 1.3 nM x min, 
n = 6 cells Fig. 4a, b). Cocaine (10 μM) and cADPR (20 μM) co-injection induced an similar 
response to that of cADPR alone, measuring 171 ± 2.6 nM in amplitude (A.U.C. of 54 ± 1.1 
nM x min, n = 6, Fig. 4a, b), while microinjection of a higher concentration of cADPR (50 
μM) induced a proportionally higher response, of 629 ± 3.7 nM (A.U.C. of 326 ± 2.8 nM x 
min, n = 6 cells, Fig. 4a, b), indicating that 20 μM cADPR produced a submaximal effect. 
Thus, cocaine does not enhance cADPR-mediated Ca2+ signaling in nAcc neurons.
Since diacylglycerol (DAG) has been reported to promote TRPC activation downstream of 
phospholipase C [36], we tested the effect of the membrane-permeable DAG analogue 1-
oleoyl-2-acetyl-sn-glycerol (OAG) on D1-expressing nAcc neurons. Application of OAG 
(75 μM) in cells incubated with Ca2+-free saline elicited no effect (Fig. 4c), while addition 
of Ca2+ to the extracellular medium unmasked a response measuring 251 ± 7.8 nM (A.U.C. 
of 1183 ± 9.3 nM x min, n = 12 neurons, Fig. 4c, d). A likewise effect was produced by 75 
μM OAG in cells treated with 10 μM cocaine: no response in absence of extracellular Ca2+ 
and an [Ca2+]i elevation by 258 ± 6.7 nM (A.U.C. of 1164 ± 9.7 nM x min, n = 12, Fig. 4c, 
d) upon changing to Ca2+-containing saline. Since absence of a cocaine-enhancing effect 
may occur as a consequence of the employment of a concentration of OAG eliciting a 
maximal response, we tested the effect of 100 μM OAG and noted an increase in [Ca2+]i by 
383 ± 11.8 nM upon Ca2+ addition (A.U.C. of 1847 ± 10.2 nM x min, n = 12, Fig. 4c, d), 
significantly higher than that produced by 75 μM OAG.
In D1-positive nAcc neurons, the TRPC antagonist SKF96365 (2 μM) did not block the Ca2+ 
elevation in response to KCl (30 mM) (Fig. 5), which produces depolarization-induced 
activation of voltage-gated Ca2+ channels. Thus, as we have previously reported [25], at 2 
μM SKF96365 has no antagonistic effect on voltage-gated Ca2+ channels.
3.3. Cocaine produces σ1R-mediated potentiation of the Ca2+ response triggered by ATP
Next, we examined the effect of cocaine on ATP, an IP3-generating molecule, in D1-
expressing accumbens neurons. To confirm that ATP mobilizes IP3-sensitive Ca2+ stores in 
nAcc neurons, we first examined the effect of extracellular application of ATP (20 μM) on 
[Ca2+]i in Ca2+-free saline, in the absence and presence of inhibitors of endoplasmic 
reticulum and lysosomal Ca2+ release channels. In the absence of extracellular Ca2+, ATP 
(20 μM) elevated [Ca2+]i of nAcc neurons by 278 ± 3.6 nM (A.U.C. of 78.8 ± 3.1 nM x min, 
n = 9 cells, Fig. 6a, b). Blockade of IP3Rs with XeC (10 μM, 15 min) and 2-APB (100 μM, 
15 min), but not inhibition of ryanodine receptors with ryanodine (Ry, 10 μM, 1h) or of 
lysosomal NAADP-sensitive two pore channels with Ned-19 (5 μM, 15 min) [37], abolished 
the Ca2+ response of nAcc neurons to ATP, indicating that it was IP3R-mediated (Fig. 6a). 
In the presence of these blockers, ATP increased [Ca2+]i by 23 ± 2.7 nM (XeC + 2-APB; 
A.U.C. of 5.6 ± 1.8 nM x min, n = 9 cells), by 269 ± 3.1 nM (Ry; A.U.C. of 74.7 ± 3.8 nM x 
min, n = 9) and by 274 ± 4.9 nM (Ned-19; A.U.C. of 77.3 ± 3.7 nM x min, n = 9), 
respectively (Fig. 6b).
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In Ca2+-containing saline, application of ATP (20 μM) alone elevated [Ca2+]i of D1-positive 
neurons by 377 ± 4.8 nM (A.U.C. of 108 ± 4.4 nM x min, n = 29 cells, Fig. 6c, d). 
Combined administration of cocaine (10 μM) and ATP (20 μM) produced a greatly 
potentiated increase in [Ca2+]i, measuring 613 ± 8.6 nM in amplitude and with an A.U.C. of 
247 ± 4.3 nM x min (n = 47 cells, Fig. 6c, d). The cocaine-induced enhancement was 
completely abrogated by pretreatment of cells with σ1R antagonist BD-1063 (10 μM, 20 
min) or with the TRPC blocker SKF96365 (2 μM, 20 min), when the Ca2+ response was 
similar to that promoted by ATP alone; Δ[Ca2+]i was 364 ± 6.1 nM (A.U.C. of 103 ± 4.6 nM 
x min, n = 31) in the case of BD-1063 and 272 ± 5.7 nM (A.U.C. of 79 ± 5.2 nM x min, n = 
28) in the case of SKF96365 (Fig. 6c, d). In presence of BAPTA-AM (200 μM, 30 min), co-
administration of cocaine and ATP no longer elicited a significant increase in [Ca2+]i 
(amplitude of 23 ± 3.5 nM, A.U.C. of 15 ± 2.3 nM x min, n = 42, Fig. 6c, d).
3.4. Intracellular microinjection of cocaine amplifies IP3-induced depolarization via σ1Rs
The mean resting potential of dissociated D1-positive nAcc neurons was −71.6 ± 0.02 mV (n 
= 258 cells depolarizing in response to SKF83959 in the preliminary screen test). 
Microinjection of cocaine or control vehicle had no effect on neuronal membrane potential; 
ΔVm were −1.2 ± 0.34 mV (n = 6) and −0.9 ± 0.47 mV (n = 6), respectively, (Fig. 7a, b). 
Intracellular administration of IP3 (20 nM) produced a slight and rather transient 
depolarization of 5.12 ± 0.42 mV, which in the presence of co-injected cocaine (10 μM) was 
converted to a greatly enhanced and more prolonged response, measuring 9.77 ± 0.53 mV in 
amplitude (Fig. 7c, d). The cocaine-dependent component of the effect was abolished upon 
blocking σ1Rs with BD-1063 (10 μM, 20 min pretreatment), when the combined 
administration of IP3 and cocaine depolarized neuronal membrane potential by 5.53 ± 0.39 
mV (n = 6), similar to IP3 injection alone (Fig. 7c, d). In presence of the Ca2+ chelator 
BAPTA-AM (200 μM, 30 min) or of TRPC inhibitor SKF96365 (2 μM, 20 min), the IP3 and 
cocaine-triggered depolarization were lost, the changes in resting membrane potential 
measuring 0.79 ± 0.62 mV (n = 6) and 1.34 ± 0.47 mV (n = 6), respectively (Fig. 7c, d).
3.5. Cocaine enhances ATP-elicited depolarization of D1-positive nAcc neurons
Cocaine produced a likewise augmentation of the amplitude and duration of the 
depolarization promoted by the IP3-generating molecule ATP (Fig. 8a). ATP (20 μM) 
depolarized D1-expressing nAcc neurons by 6.71 ± 0.39 mV (n = 36) in absence and by 
11.63 ± 0.54 (n = 52 cells) in presence of co-applied cocaine (10 μM) (Fig. 8b). Pretreatment 
of cells with σ1R blocker BD-1063 (10 μM, 20 min) virtually eliminated the cocaine-
mediated amplification, as neurons depolarized only by 7.38 ± 0.47 mV (n = 46) when ATP 
and cocaine were co-applied in this condition (Fig. 8a, b). The depolarization triggered by 
combined administration of cocaine and ATP measured 5.68 ± 0.53 mV (n = 39) when 
neurons were preincubated with the fast Ca2+ chelator BAPTA-AM (200 μM, 30 min) and 
5.92 ± 0.41 mV (n = 43) upon pretreatment with TRPC blocker SKF96365 (2 μM, 20 min) 
(Fig. 8a, b). These results support a contribution of the [Ca2+]i elevation and of cation entry 
via TRPC in the mechanism of cocaine-induced enhancement of ATP effects in D1-positive 
nAcc neurons.
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3.6. Blockade of σ1Rs or TRPC in the nAcc reverses cocaine-induced hyperlocomotion and 
sensitization in vivo
The role of σ1Rs and TRPC in the nAcc in cocaine-induced hyperactivity was investigated 
in the rat. To this end, the ability of the selective σ1R antagonist BD-1063 (80 μg/0.5 μl, 
intra-nAcc), and the TRPC blocker SKF96365 (20 μg/0.5 μl, intra-nAcc), to attenuate acute 
cocaine (15 mg/kg ip)-induced hyperlocomotion was tested. Two-way ANOVA with 
repeated measures over days revealed a statistically significant main effect of day (F5,202 = 
22.821, p < 0.001), a significant treatment main effect (F5, 202 = 13.994, p < 0.001) and no 
treatment × day interaction (F25,202 = 1.296, p= 0.175). Post test analysis revealed that 
administration of cocaine following aCSF infusion produced a significant increase in 
ambulatory activity on Days 2–5 compared with aCSF + vehicle administration (Fig. 8b; aC 
vs aV; p < 0.05). Pretreatment with BD-1063 or SKF96365 into the accumbens significantly 
inhibited cocaine-induced locomotion on Days 2–5 (aC vs BC or SC, p<0.05). Infusion of 
BD-1063 or SKF96365 alone (prior to a saline injection) did not alter locomotion when 
compared to the levels of activity after aCSF infusion and saline injection (Fig. 8b, BV or 
SV vs aV; p > 0.05). On day 5, activity of the SKF96365 + cocaine group was different 
from the three vehicle control groups (SC vs aV/BV/SV; post hoc p < 0.05), but 
significantly lower than the cocaine alone group (SC vs aV; p < 0.05).
Locomotor sensitization occurs as the result of repeated cocaine administration. The ability 
of the BD-1063 and SKF96365 to block the development of locomotor sensitization to 
repeated cocaine was investigated. Seven days following the five daily treatments described 
above, all rats were challenged with cocaine (15 mg/kg ip) on Day 12 without further 
intracranial infusions and activity recorded. Rats receiving daily intra-accumbens aCSF plus 
cocaine for 5 days showed significantly greater ambulatory response to the cocaine 
challenge on Day 12 than did rats receiving daily intra-accumbens aCSF plus saline, 
demonstrating locomotor sensitization (Fig. 9b; aC vs aV, p < 0.05). Activity following the 
cocaine challenge of the groups receiving daily intra-accumbens BD-1063 or SKF96365 
plus cocaine was significantly lower than those receiving aCSF plus cocaine (BC/SC vs aC, 
p < 0.05). These data demonstrate that cocaine-induced hyperactivity and sensitization can 
be blocked by pretreatment with the σ1R antagonist BD-1063 or TRPC blocker SFK96365.
4. Discussion
Emerging evidence points to IP3 involvement both in σ1R-mediated signaling and in 
cocaine-promoted responses. σ1R activation potentiates not only IP3R-mediated Ca2+ 
release from the ER [24], but also IP3 formation [38, 39]. IP3R blockade at central levels 
inhibits cocaine-induced place preference in mice [40]. Cocaine binds to σ1Rs with a 2 μM 
affinity [9]. In vivo studies have shown that pharmacologically relevant doses of cocaine 
produce striatal levels of the drug in a low μM range [41, 42]. For instance, it has been 
reported that after systemic administration to mice of a 10 mg/kg dose of cocaine, a peak 
value for cocaine of 2.6 μg/g (~7.6 – 8.5 μM) at 5 min was seen in the brain, whereas after a 
25 mg/kg the peak value was 6.7 μg/g (~19.7 – 22.1 μM) [41]; moreover, the cocaine 
concentrations in the brain were always higher than those in the plasma, with an average 
brain/plasma ratio of 7 [41].
Barr et al. Page 10









We report here that, although ineffective by itself at concentrations up to 100 μM, at 10 μM 
cocaine strongly enhances IP3-induced Ca2+ responses in D1-expressing nAcc neurons by 
activating intracellularly-located σ1Rs, significantly shifting the IP3 concentration-response 
curve to the left. Our finding is supported by previous indications that in NG108 cells, 
cocaine promotes σ1R-dependent increase in IP3R3 sensitivity for IP3, further translated into 
augmented Ca2+ efflux from the ER in the presence of IP3-generating mediators such as 
bradykinin [10, 43]. Accordingly, we found that the Ca2+ response induced by ATP (which 
clearly mobilized only IP3-sensitive intracellular Ca2+ stores in our paradigm) was similarly 
enhanced by cocaine via σ1Rs. Conversely, cocaine had no effect on the ryanodine receptor-
mediated Ca2+ release.
We note two potential implications of our findings. On the one hand, cocaine is a dopamine 
transporter blocker, producing indirect activation of phospholipase C β-coupled D1-like 
receptors, which results in IP3 accumulation in the striatum [44]. Thus, one putative 
mechanism of cocaine-induced activation of D1-positive neurons in vivo would include two 
steps: a dopamine-dependent increase in IP3 levels, likely associated with an increase in 
[Ca2+]i, followed by a dopamine-independent, cocaine-directed activation of σ1Rs, resulting 
in potentiation of the initial Ca2+ response.
On the other hand, increased levels of ATP synthase β-chain have been found in the nAcc of 
cocaine-overdose victims [45], suggesting that cocaine may elicit local ATP elevation in this 
brain region. σ1Rs promote ATP production via increased mitochondrial Ca2+ uptake [46] 
and potentiate ATP-triggered Ca2+ mobilization [47]. ATP induces IP3-mediated Ca2+ 
release by activating Gq-coupled P2Y(1) receptors, which are expressed by neurons in the 
nAcc [48]. In view of our present findings, once ATP levels in the nAcc increase, cocaine is 
expected to directly activate D1-positive neurons, by σ1R-dependently enhancing ATP 
effects.
Another important result of our study is that cocaine-triggered enhancement of IP3- or ATP-
mediated Ca2+ elevation was proportionally translated into a σ1R-dependent augmentation 
of IP3- or ATP-induced depolarization of D1-expressing nAcc neurons. Experiments using 
the fast Ca2+ chelator BAPTA-AM clearly indicate contingency of the depolarization on 
[Ca2+]i increase.
Changes in resting membrane potential determine the ease with which excitatory synaptic 
inputs bring the membrane potential closer to the threshold for action potential firing. In 
vivo, the membrane potential of D1-positive medium spiny neurons oscillates between 
“down-states” characterized by highly negative values (ranging from −75 to −85 mV) and 
“up-states” consisting in periodic plateau depolarizations (Vm ~ −55 mV) triggered by 
convergent, temporally coherent excitatory synaptic inputs [49, 50]. Accordingly, we found 
that the resting membrane potential of dissociated D1-positive neurons was ~ −72 mV. 
Given that dopamine depolarizes D1-expressing neurons and that under conditions of 
cocaine administration synaptic dopamine levels are increased, we propose that cocaine-
induced σ1R activation favors the D1 pathway in the nAcc. Indeed, we found that cocaine-
mediated locomotor hyperactivity and sensitization is significantly attenuated by prior 
administration of a σ1R antagonist into the rat nAcc.
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IP3-dependent Ca2+ signaling has been shown to be involved in the activation of TRPC [25, 
51]. TRPC subtypes 4 and 5 are expressed in the rodent nAcc at low and moderate levels, 
respectively [52], and have been implicated in cocaine-triggered motivation/reward-directed 
behaviors [53, 54]. Rats lacking a functional trpc4 gene showed reduced cocaine self-
administration [54]; mice with selective trpc5 knock-down in the forebrain exhibited 
increased cocaine self-administration on the first day of testing, although were similar to 
wild-type mice during the maintenance phase of self-administration [53]. We report here 
that TRPC are critical for cocaine-triggered amplification of IP3/ATP-dependent Ca2+ 
responses and membrane potential changes in D1-expressing nAcc neurons. Importantly, 
cocaine does not enhance OAG-mediated Ca2+ signaling, indication that IP3 is a critical 
molecule in the pathway linking cocaine and TRPC. Moreover, the TRPC-involving route in 
the nAcc mediates cocaine-induced hyperlocomotion and locomotor sensitization, as 
indicated by our experiments using intra-accumbal delivery of a TRPC blocker.
Thus, we propose a new mechanism by which cocaine stimulates or maintains D1-positive 
neurons in active state: σ1R activation at the ER, resulting in dissociation from inhibitory 
proteins [10, 11, 43] and consequent increases in IP3R3 sensitivity for IP3 [10, 43]. This in 
turn correlates with increased Ca2+ efflux from the ER, which promotes TRPC opening [25, 
51] and cation entry, resulting in further [Ca2+]i increase and membrane depolarization, 
converging to locomotor hyperactivity and sensitization (Fig. 10).
Previous studies examining cocaine-induced σ1R activation noted a potential cocaine-
mediated translocation of σ1Rs from the ER to the plasma membrane of cells in striatal 
slices, where σ1Rs interact with a D1-D1 homomer [22] or a heteromer of D1 and H3 
histamine receptor [55], thus facilitating D1-mediated effects. Another σ1R-dependent effect 
of cocaine involves formation of higher order oligomers between σ1R and D2 receptors in 
mouse striatal slices and inhibition of signaling via D2 [23]. These plasma membrane-
initiated mechanisms were clearly demonstrated in transfected cells treated with 15–30 μM 
cocaine, while their potential occurrence in brain striatal slices was apparent at higher 
cocaine concentrations (150 μM) meant to allow diffusion into the tissue [22, 23, 55]. 
Another study identified a cocaine-induced association of σ1R and K+ channels at the 
plasmelemma of nAcc shell neurons with implications for cocaine-promoted changes in 
neuronal excitability and associated behavioral sensitization [56]. Our study is the first 
indication of σ1R-directed effects of cocaine occurring upon their intracellular activation in 
nAcc neurons, and not upon translocation at the plasma membrane. Moreover, we identify a 
previously unknown mechanism of cocaine action in D1-expressing nAcc neurons, involving 
TRPC activation, providing a putative explanation of the in vivo results here shown, as well 
as those of others [54].
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ANOVA analysis of variance
A.U.C area under curve
BAPTA 1,2-Bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrakis
[Ca2+]i intracellular Ca2+ concentration
DiBAC4(3) bis-(1,3-dibutylbarbituric acid) trimethine oxonol
ER endoplasmic reticulum





TRPC transient receptor potential canonical channels
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• Cocaine enhances IP3-mediated Ca2+ signaling via sigma-1-receptor (σ1R)
• This induces TRP canonical (TRPC) activation and depolarization of accumbal 
neurons
• Intra-accumbal σ1R/TRPC blockade reduces cocaine-hyperlocomotion/
sensitization.
• We show behavioral relevance of a novel cocaine-triggered pathway in the 
accumbens.
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Figure 1. Neurons of interest
a, Nucleus accumbens neurons express both σ1Rs and IP3R3 proteins; NG108 cells were 
used as positive control; β-actin was used as an internal control. Results are representative 
for three independent experiments. b, Functional characterization of phosphatidylinositol-
linked D1 dopamine receptor expression in nAcc neurons: left panel -averaged Ca2+ 
responses induced by D1 agonist SKF83959 (10 μM) upon extracellular administration to 
D1-expressing nAcc neurons incubated in Ca2+-containing saline (left) or in Ca2+-free 
saline, in absence (middle) and presence of IP3R blockers xestospongin C (XeC) and 2-APB 
(right); right panel – comparison of the Ca2+ responses produced by SKF83959 in the 
mentioned conditions; P < 0.00001 compared to basal Ca2+ levels (*) or to SKF83959 in 
Ca2+-free HBSS (**). Neurons not responding to SKF83959 with an increase in [Ca2+]i 
were not used further for experiments. c, Lack of effect of cocaine microinjection alone on 
[Ca2+]i of D1-positive nAcc neurons: left - averaged tracings of the Ca2+ responses 
produced by intracellular microinjection of either control buffer or cocaine (C, 100 μM); 
right - Comparison of the amplitudes and areas under curve (A.U.C.) of the Ca2+ responses; 
lower concentrations of cocaine were similarly ineffective.
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Figure 2. Cocaine shifts to the left the IP3-induced concentration-Ca2+ response curve via σ1R
a, Averaged Ca2+ responses elicited by IP3 (20 nM) microinjection alone or in combination 
with cocaine (10 μM) or by IP3 (20 nM) and cocaine (10 μM) coinjection upon σ1R 
blockade with either BD-1063 (BD, 10 μM) or NE-100 (NE, 3 μM). b, Concentration-
response curves indicating the effect of IP3 (1, 10, 20, 30, 40, 50 and 60 nM) microinjection 
into D1-expressing nAcc neurons (incubated in Ca2+-free saline) when injected alone (black) 
or in combination with 10 μM cocaine (red); P < 0.005(*), P <0.001(**) and P < 
0.00001(***); comparison of the two data sets yielded statistical significance for the two 
fits: F = 5.1715; P = 0.0378 < 0.05. c, Comparison of the Ca2+ increases triggered by 
treatments mentioned in a; P < 0.00001 compared with IP3 (*) or to combined cocaine and 
IP3 microinjection (#).
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Figure 3. σ1R-mediated enhancement by microinjected cocaine of the IP3-induced [Ca2+]i 
increase
a, Averaged tracings of the Ca2+ responses elicited by intracellular microinjection of IP3 (20 
nM) alone or in presence of σ1R antagonist BD-1063 (BD, 10 μM); or cocaine (C, 10μM) 
and IP3 (20 nM) in absence, or presence of either BD (10 μM) or NE-100 (NE, 3 μM); the 
fast Ca2+ chelator BAPTA-AM (200 μM); or TRPC blocker SKF96365 (SKF, 2 μM). b, 
Comparison of the amplitudes and areas under curve (A.U.C.) of the Ca2+ responses; P < 
0.00001 compared with IP3 alone (*), with combined cocaine and IP3 microinjection (#), or 
with all other treatment groups (+). c, Fura-2 AM fluorescence ratios (340 nm/380 nm) of 
cultured nAcc neurons before and after D1 agonist SKF83959 (10 μM), after washing of 
SKF83959 and after microinjection of indicated compounds in absence and presence of the 
antagonist pretreatment indicated in the right side; cold colors indicate low levels of [Ca2+]i; 
hot colors indicate high levels of [Ca2+]i; fluorescence scale (0–2) is magnified in each panel 
showing the effect of injected compounds.
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Figure 4. Cocaine does not enhance cADPR or OAG-mediated Ca2+ signaling in nAcc neurons
a, Averaged Ca2+ tracings indicating the response of Ca2+-free saline-incubated neurons to 
microinjection of 20 μM cADPR alone or co-injected with 10 μM cocaine or to 
microinjection of 50 μM cADPR. b, Comparison of the amplitudes and areas under curve of 
the Ca2+ responses to treatments indicated in a; P < 0.00001 compared to basal Ca2+ levels 
(*) or to the effect of 20 μM cADPR (**). c, Averaged Ca2+ tracings corresponding to the 
effects produced by OAG (75 μM) in Ca2+-free and Ca2+-containing saline, in absence and 
presence of cocaine (10 μM), or to the effect of 100 μM OAG in Ca2+-negative and Ca2+-
positive conditions. d, Comparison of the effects in Ca2+-containing saline induced by 
treatments indicated in d; P < 0.00001 compared to basal Ca2+ levels (*) or to the effect of 
75 μM OAG in presence of extracellular Ca2+ (**).
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Figure 5. SKF96365 (2 μM) is devoid of inhibitory activity at voltage-gated Ca2+ channels in 
nAcc neurons
a, Averaged Ca2+ responses induced by 30 mM KCl in absence and presence of SKF96365 
(2 μM). b, The amplitudes of the Ca2+ increases produced by KCl measured 357 ± 5.6 nM 
(n = 31 cells) in absence and 351 ± 5.9 nM (n = 37) in presence of SKF96365; the areas 
under curve were 828 ± 11.3nM x min and 817 ± 10.9 nM x min, respectively.
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Figure 6. Cocaine potentiates the Ca2+ response of nAcc neurons to IP3-generating molecules
a–b, ATP promotes Ca2+ mobilization from IP3-sensitive pools in accumbens neurons: a, 
Averaged tracings of the Ca2+ responses elicited by ATP (20 μM) in Ca2+-free saline, in 
absence or presence of IP3R blockers xestospongin C (XeC) and 2-aminoethoxydiphenyl 
borate (2-APB); ryanodine receptor blocker ryanodine (Ry); or lysosomal two-pore channel 
inhibitor Ned-19. b, Comparison of the amplitudes and the areas under curve (A.U.C.) of the 
Ca2+ increases produced by the indicated treatments; *P < 0.00001 compared with all other 
treatment groups. c–d, Cocaine produces σ1R-dependent potentiation of the ATP-induced 
Ca2+ elevation in D1-expressing accumbens neurons: c, Averaged tracings of the Ca2+ 
responses induced by bath application of ATP (20 μM) or cocaine (C, 10 μM) and ATP (20 
μM), in naïve neurons or neurons incubated with either σ1R antagonist BD-1063 (BD, 10 
μM); or Ca2+ chelator BAPTA-AM (200 μM); or TRPC blocker SKF96365 (SKF, 2 μM). d, 
Comparison of the amplitudes and the areas under curve (A.U.C.) of the Ca2+ responses 
produced by the indicated treatments; P < 0.00001 compared with ATP alone (*), with 
combined cocaine and ATP administration (#), or with all other treatment groups (+).
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Figure 7. Intracellular microinjection of cocaine enhances IP3-induced depolarization in the 
nAcc
a–b, Cocaine microinjection alone does not modify neuronal membrane potential: a, 
Representative recordings of the resting membrane potential of D1-expressing nAcc neurons 
treated intracellularly with either control vehicle or cocaine (C, 10 μM, final intracellular 
concentration). b, Neither control vehicle microinjection or cocaine microinjection did 
produce a significant change in neuronal membrane potential. c-d, Cocaine potentiates the 
IP3-dependent depolarization of D1-expressing accumbens neurons: c, Characteristic 
changes in resting membrane potential of neurons microinjected with either IP3 (20 nM) or 
IP3 (20 nM) and cocaine (C, 10 μM) in absence and presence of bath-applied σ1R inhibitor 
BD-1063 (BD, 10 μM), of the Ca2+ chelator BAPTA-AM (200 μM) or of TRPC blocker 
SKF96365 (SKF, 2 μM). d, Comparison of the amplitudes of the depolarizations induced by 
treatment conditions described in c; P < 0.00001 compared with IP3 injection alone (*), with 
combined cocaine and IP3 microinjection (#), or with all other treatment groups (+).
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Figure 8. Cocaine enhances the ATP-induced depolarization
a, Typical recordings of membrane potential modifications of D1-expressing accumbens 
neurons treated extracellularly with ATP (20 μM) or ATP (20 μM) and cocaine (C, 10 μM) 
in absence and presence of the σ1R inhibitor BD-1063 (BD, 10 μM), of the Ca2+ chelator 
BAPTA-AM (200 μM) or of the TRPC blocker SKF96365 (SKF, 2 μM). b, Comparison of 
the amplitudes of the depolarizations induced by treatments described in a; P < 0.00001 
compared with ATP alone (*) or with combined cocaine and ATP administration (#).
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Figure 9. Cocaine-induced behavioral hyperactivity and sensitization involves σ1R and TRPC
a, Coronal section indicating the distribution of infusion sites in the nAcc for the 35 
experimental animals (aCSF-saline, n = 5; aCSF-cocaine, n = 7; BD-1063-saline, n = 5; 
BD-1063-cocaine, n = 6; SKF96365-saline, n = 6; SKF96365-cocaine, n = 6). Injection sites 
may appear fewer than the reported number of rats because of overlap of placements. b, 
Pretreatment with BD-1063 (80 μg/side) or SKF96365 (20 μg/side) administered 20 min 
prior to each cocaine injection for 5 days significantly inhibited cocaine-induced ambulatory 
activity on Days 2–5, and the development of repeated cocaine-induced locomotor 
sensitization on Day 12. Repeated administration of either antagonist alone did not alter 
levels of locomotion; *P < 0.05, aCSF-cocaine rats were significantly different from all 
other experimental groups; # SKF96365-cocaine rats were significantly different from 
aCSF-saline, BD-1063-saline and SKF96365-saline on day 5. Data are presented as mean +/
− sem ambulatory counts/60 minutes; abbreviations: aV, intra-nAcc aCSF + ip saline 
vehicle; BV, intra-nAcc BD-1063 + ip saline vehicle; SVm intra-nAcc SFK96365 + ip 
saline vehicle; aC, intra-nAcc aCSF + ip cocaine; BC, intra-nAcc BD1063 + ip cocaine; SC, 
intra-nAcc SKF-96365 + ip cocaine.
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Figure 10. Mechanism of cocaine-induced activation of D1-expressing nAcc neurons
Cocaine activates endoplasmic reticulum (ER)-located σ1Rs and potentiates Ca2+ release 
from the ER via IP3 receptors type 3 (IP3 R3) promoted by GPCR agonists (Gq-coupled, 
such as ATP). The increase in cytosolic Ca2+ triggers activation of TRPC and additional 
Ca2+ entry, as well as Na2+ entry, followed by depolarization and activation of these 
neurons, triggering hyperlocomotion and behavioral sensitization in vivo.
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